Synthesis and biological evaluation of Oblongifolin C derivatives as c-Met inhibitors
- Bioorg Med Chem. 2016 Sep 15;24(18):4120-4128. doi: 10.1016/j.bmc.2016.06.054.
- 1. School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Cai Lun Lu 1200, Shanghai 201203, People's Republic of China; Engineering Research Center of Shanghai Colleges for TCM New Drug Discovery, Shanghai 201203, People's Republic of China.
- 2. School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Cai Lun Lu 1200, Shanghai 201203, People's Republic of China; Engineering Research Center of Shanghai Colleges for TCM New Drug Discovery, Shanghai 201203, People's Republic of China. Electronic address: [email protected].
- 3. School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Cai Lun Lu 1200, Shanghai 201203, People's Republic of China; Engineering Research Center of Shanghai Colleges for TCM New Drug Discovery, Shanghai 201203, People's Republic of China. Electronic address: [email protected].
Oblongifolin C, one of the polyprenylated benzoylphloroglucinol natural products (PPAPs) isolated from the fruits of Garcinia yunnanensis Hu, was recently discovered to be a potent anti-tumor agent. A collection of 12 derivatives with modifications on the benzophenone moieties were synthesized and tested for c-Met kinase inhibition and cytotoxicity against the HepG2, Miapaca-2, HCC827, Hela, A549, AGS, and HT-29 cell lines in vitro. An oxidized derivative, 10, was found to possess strong inhibition and anti-migration properties in the HCC827 cell line and serves as a potential lead compound for the development of new Anticancer drugs. In addition, structure-activity relationships (SAR) were also evaluated to provide key information for future Anticancer drug development.